Ocular Therapeutix prices $25M common stock offering
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Investment Banking Essentials Newsletter April Edition - 2022
Ocular Therapeutix Inc. priced an underwritten offering of shares at $7 apiece to raise $25 million in proceeds.
The company plans to issue 3,571,429 shares with Cantor Fitzgerald & Co. acting as the sole book runner.